Event: AI and megadata, how will they revolutionize tomorrow’s medical research and practice?

Event: AI and megadata, how will they revolutionize tomorrow’s medical research and practice?

Feb 1, 2023 | Event, Innovation, News

The Conseil d’État’s study “Artificial Intelligence and Public Action” of August 2022, raised several questions around the use of artificial intelligence (AI) and megadata by public authorities. These issues are particularly important in the healthcare sector, where the most recent technological developments suggest new ways of using data and artificial intelligence, for the benefit of patients.

To address these issues, the Conseil d’État, the CNIL and Alliance IHU France are organizing a day of work and discussion on February 10, 2023, from 9 a.m. to 3:45 p.m., bringing together doctors, researchers, regulators, industrialists and entrepreneurs, and political decision-makers: AI and megadata, how will they revolutionize tomorrow’s research and medical practice?

The debates are accessible to all via the Conseil d’État website.

Creativity management and innovation in healthcare: the IHU Strasbourg model presented at CreaSXB

Creativity management and innovation in healthcare: the IHU Strasbourg model presented at CreaSXB

Nov 4, 2022 | Education, Event, Innovation, News

The IHU model presented at the 13th edition of the Autumn School on Creativity Management

From November 7 to 11 at key locations in Strasbourg and surroundings

Organized by the BETA (Bureau d’Économie Théorique et Appliquée) of the University of Strasbourg and MosaiC, Pôle créativité & innovation – HEC Montréal, the Autumn School in Creativity Management offers a rich and diversified week-long program.

Promoting the acquisition of new knowledge through new practices around creativity in our organizations and our territories, this week-long training event draws on the real-life skills of its participants: entrepreneurs, executives, decision-makers, managers, creators from various fields of activity, general management, marketing, innovation and R&D managers, young entrepreneurs and associates.

Jean-Luc Dimarcq, Director of Development of the IHU, will speak on the subject of the IHU’s ‘original models to boost innovation in health’ on Wednesday, November 9 at 2pm at the European Doctoral College, 46 Boulevard de la Victoire, Strasbourg.

Find all the information here: https://www.creasxb.fr/
Register here: https://www.creasxb.fr/inscription/

L’IHU Strasbourg is awarded one of the 13 Experimental Authorizations from ARCEP for its 5G-Connected Operating Room Project

L’IHU Strasbourg is awarded one of the 13 Experimental Authorizations from ARCEP for its 5G-Connected Operating Room Project

Oct 18, 2022 | Event, Innovation, News, Valorization

As part of the Government’s 5G Mission entrusted to Philippe Herbet, the Electronic Communications, Postal and Print media distribution Regulatory Authority (Arcep) authorized on October 12 the experimentation in the 3.8 – 4.0 GHz band at the IHU Strasbourg in order to promote access to 5G for industrialists and “vertical” players (local authorities, universities, research laboratories, etc.).

The IHU has been granted one of the 13 experimental authorizations issued by Arcep, covering various sectors of the economy: industry, energy and health.

The thirteen experimental authorizations in the 3.8 - 4.0 GHz band as of October 12, 2022 (Source: Arcep)

The thirteen experimental authorizations in the 3.8 – 4.0 GHz band as of October 12, 2022 (Source: Arcep)

 

Strasbourg University-Hospital Institute (IHU)

A part of the Franco-German “5G-OR” project, the experiment aims to create the first demo of a new generation of operating room communicating within a private 5G network, for personalized and secure minimally invasive interventions, with the objective of improving patient benefit. The French team involves two institutes created by the Investissements d’Avenir program – the Strasbourg University Hospital Institute and the b<>com Technological Research Institute, as well as the innovative company RDS Diagnostics.